Cargando…
Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme
BACKGROUND: The Compassionate Access Scheme (CAS) being delivered through the Queensland Children’s Hospital is designed to allow access to an investigational purified Cannabidiol oral solution to paediatric patients with severe refractory epilepsy. The objectives of this study were to conduct semi-...
Autores principales: | Harte, S., Singh, Y., Malone, S., Heussler, H., Wallace, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832815/ https://www.ncbi.nlm.nih.gov/pubmed/35144615 http://dx.doi.org/10.1186/s12913-022-07592-4 |
Ejemplares similares
-
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020) -
Parent and Caregiver Perspectives towards Cannabidiol as a Treatment for Fragile X Syndrome
por: Maertens, Madison, et al.
Publicado: (2022) -
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy
por: Aguirre-Velázquez, Carlos G.
Publicado: (2017) -
Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature
por: Moreira, Gabriela Araujo, et al.
Publicado: (2022) -
Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)